Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2024 Mar;45(2):146-147.
doi: 10.1007/s00292-024-01297-7.

Erratum zu: Molekulare Klassifikation des Endometriumkarzinoms – ein kurzer Überblick

[Article in German]
Grit Gesine Ruth Hiller  1 , Anne Kathrin Höhn  2 , Doris Mayr  3   4 , Christine E Brambs  5 , Lars-Christian Horn  2   4
Affiliations
Published Erratum

Erratum zu: Molekulare Klassifikation des Endometriumkarzinoms – ein kurzer Überblick

[Article in German]
Grit Gesine Ruth Hiller et al. Pathologie (Heidelb). 2024 Mar.
No abstract available

PubMed Disclaimer

Erratum for

References

Literatur

    1. Carlson J, McCluggage WG (2019) Reclassifying endometrial carcinomas with a combined morphological and molecular approach. Curr Opin Oncol 31(5):411–419 - DOI - PubMed
    1. Jamieson A, Bosse T, McAlpine JN (2021) The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer. Ther Adv Med Oncol 13:17588359211035959 - DOI - PubMed - PMC
    1. Vermij L, Smit V, Nout R, Bosse T (2020) Incorporation of molecular characteristics into endometrial cancer management. Histopathology 76(1):52–63 - DOI - PubMed
    1. TCGA—Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67–73 - DOI
    1. León-Castillo A, de Boer SM, Powell ME, Mileshkin LR, Mackay HJ, Leary A, Nijman HW, Singh N, Pollock PM, Bessette P, Fyles A, Haie-Meder C, Smit VTHBM, Edmondson RJ, Putter H, Kitchener HC, Crosbie EJ, de Bruyn M, Nout RA, Horeweg N, Creutzberg CL, Bosse T, TransPORTEC consortium (2020) Molecular classification of the PORTEC‑3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy. J Clin Oncol 38(29):3388–3397 - DOI - PubMed - PMC

Publication types